Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 55. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_1443ReovirusReoT3DRNAReoviridaeNoneYesNoNoNCIHuman NSCLC cell lineNCIH460NANAXTT assayLog10 pfu/cell20% cell survived 48 hours after post infectionNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1452ReovirusReoT3DRNAReoviridaeNoneNoVirus strain in combination with palcitaxel (100 micromolar)NoNCIHuman NSCLC cell lineNCIH460NANADose response analysis curveLog10 pfu/cell100% cell death after 4 daysNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1453ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.003 +/- 0.001 micromolar, 1:53)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell50% cell death occurs at 0.903 CI valueNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1459ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.003 +/- 0.001 micromolar, 1:53)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell75% cell death at CI value 0.221NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1465ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.003 +/- 0.001 micromolar, 1:53)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.057NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1471ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.003 +/- 0.001 micromolar, 1:533)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell50% cell death occurs at 0.193 CI valueNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1477ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.003 +/- 0.001 micromolar, 1:533)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell75% cell death at CI value 0.042NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1483ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.003 +/- 0.001 micromolar, 1:533)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.013NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1489ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (5.31+/-1.21, ratio is 1:53)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.875NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1495ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (5.31+/-1.21, ratio is 1:53)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell75% death at CI value 0.313NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1501ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (5.31+/-1.21, ratio is 1:53)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.112NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1507ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (5.31+/-1.21, ratio is 1:533)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.061NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1513ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (5.31+/-1.21, ratio is 1:533)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell75% death at CI value 0.006NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1519ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (5.31+/-1.21, ratio is 1:533)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.129NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1525ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.01+/- 0.003, 1:53)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.199NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1531ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.01+/- 0.003, 1:53)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell75 % cell death at CI 0.126NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1537ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.01+/- 0.003, 1:53)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.126NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1543ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.01+/- 0.003, 1:533)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 0.006NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1549ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.01+/- 0.003, 1:533)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 0.017NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1555ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.01+/- 0.003, 1:533)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.054NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1561ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(0.92+/-0.35nm, 1:5.3)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 0.255NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1567ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(0.92+/-0.35nm, 1:5.3)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 0.149NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1573ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(0.92+/-0.35nm, 1:5.3)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.089NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1579ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(0.92+/-0.35nm, 1:53.3)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 0.069NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1585ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(0.92+/-0.35nm, 1:53.3)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 0.045NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1591ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(0.92+/-0.35nm, 1:53.3)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.031NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_2775AdenovirusAd.sp-E1A-TSLC1DNAAdenoviridaeDeletion of 24bp with in E1A gene and insertion of TSLC1 geneYesNoNoATCCHuman lung cancer cell lineNCI-H460NANACrystal violet staining0.1 MOIModerate cell deathNoNoNA No responseNAInduction of apotosis by virus in cancer cell line as measured by TUNEL assayNANA23503473
OV_2776AdenovirusAd.sp-E1A-TSLC1DNAAdenoviridaeDeletion of 24bp with in E1A gene and insertion of TSLC1 geneYesNoNoATCCHuman lung cancer cell lineNCI-H460NANACrystal violet staining0.5 MOIModerate cell deathNoNoNA No responseNAInduction of apotosis by virus in cancer cell line as measured by TUNEL assayNANA23503473
OV_2777AdenovirusAd.sp-E1A-TSLC1DNAAdenoviridaeDeletion of 24bp with in E1A gene and insertion of TSLC1 geneYesNoNoATCCHuman lung cancer cell lineNCI-H460NANACrystal violet staining1 MOISignificant cell deathNoNoNA No responseNAInduction of apotosis by virus in cancer cell line as measured by TUNEL assayNANA23503473
OV_2778AdenovirusAd.sp-E1A-TSLC1DNAAdenoviridaeDeletion of 24bp with in E1A gene and insertion of TSLC1 geneYesNoNoATCCHuman lung cancer cell lineNCI-H460NANACrystal violet staining5 MOIAll cells was deadNoNoNA No responseNAInduction of apotosis by virus in cancer cell line as measured by TUNEL assayNANA23503473
OV_2779AdenovirusAd.sp-E1A-TSLC1DNAAdenoviridaeDeletion of 24bp with in E1A gene and insertion of TSLC1 geneYesNoNoATCCHuman lung cancer cell lineNCI-H460NANACrystal violet staining10 MOIAll cells was deadNoNoNA No responseNAInduction of apotosis by virus in cancer cell line as measured by TUNEL assayNANA23503473
OV_2800AdenovirusAd.sp-E1A-TSLC1DNAAdenoviridaeDeletion of 24bp with in E1A gene and insertion of TSLC1 geneYesNoNoATCCHuman lung cancer cell lineNCI-H460NANAMTT assay0.5 MOI90% cells are viableNoNoNA No responseNAInduction of apotosis by virus in cancer cell line as measured by TUNEL assayNANA23503473
OV_2801AdenovirusAd.sp-E1A-TSLC1DNAAdenoviridaeDeletion of 24bp with in E1A gene and insertion of TSLC1 geneYesNoNoATCCHuman lung cancer cell lineNCI-H460NANAMTT assay1 MOI80% cells are viableNoNoNA No responseNAInduction of apotosis by virus in cancer cell line as measured by TUNEL assayNANA23503473
OV_2802AdenovirusAd.sp-E1A-TSLC1DNAAdenoviridaeDeletion of 24bp with in E1A gene and insertion of TSLC1 geneYesNoNoATCCHuman lung cancer cell lineNCI-H460NANAMTT assay2 MOI80% cells are viableNoNoNA No responseNAInduction of apotosis by virus in cancer cell line as measured by TUNEL assayNANA23503473
OV_2803AdenovirusAd.sp-E1A-TSLC1DNAAdenoviridaeDeletion of 24bp with in E1A gene and insertion of TSLC1 geneYesNoNoATCCHuman lung cancer cell lineNCI-H460NANAMTT assay5 MOI70% cells are viableNoNoNA No responseNAInduction of apotosis by virus in cancer cell line as measured by TUNEL assayNANA23503473
OV_2804AdenovirusAd.sp-E1A-TSLC1DNAAdenoviridaeDeletion of 24bp with in E1A gene and insertion of TSLC1 geneYesNoNoATCCHuman lung cancer cell lineNCI-H460NANAMTT assay10 MOI60% cells are viableNoNoNA No responseNAInduction of apotosis by virus in cancer cell line as measured by TUNEL assayNANA23503473
OV_4331AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman large cell lung cancerNCI-H4604000 cells per wellNAMTT assay10 pfu99.5 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4555AdenovirusCD55-TRAIL+ CD55-MnSODDNAAdenoviridaevirus containing TRAIl and MnSOD geneYesNoNoShanghai cell collectionHuman lung carcinoma cell lineNCI-H4605.0E+4 cells per wellNAMTT assay10 MOI90% cancer cell survival after 24 hoursNoNoNA No responseNAVirus induced apoptosisNANA27080225
OV_4556AdenovirusCD55-MnSODDNAAdenoviridaevirus containing MnSOD geneYesNoNoShanghai cell collectionHuman lung carcinoma cell lineNCI-H4605.0E+4 cells per wellNAMTT assay10 MOI100% cancer cell survival after 24 hoursNoNoNA No responseNAVirus induced apoptosisNANA27080225
OV_4557AdenovirusCD55-TRAILDNAAdenoviridaevirus containing TRAIL geneYesNoNoShanghai cell collectionHuman lung carcinoma cell lineNCI-H4605.0E+4 cells per wellNAMTT assay10 MOI100% cancer cell survival after 24 hoursNoNoNA No responseNAVirus induced apoptosisNANA27080225
OV_4558AdenovirusCD55-TRAIL-IETD-MnSODDNAAdenoviridaeVirus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage siteYesNoNoShanghai cell collectionHuman lung carcinoma cell lineNCI-H4605.0E+4 cells per wellNAMTT assay10 MOI90% cancer cell survival after 24 hoursNoNoNA No responseNAVirus induced apoptosisNANA27080225
OV_4559AdenovirusCD55-TRAIL+ CD55-MnSODDNAAdenoviridaevirus containing TRAIl and MnSOD geneYesNoNoShanghai cell collectionHuman lung carcinoma cell lineNCI-H4605.0E+4 cells per wellNAMTT assay10 MOI100% cancer cell survival after 48 hoursNoNoNA No responseNAVirus induced apoptosisNANA27080225
OV_4560AdenovirusCD55-MnSODDNAAdenoviridaevirus containing MnSOD geneYesNoNoShanghai cell collectionHuman lung carcinoma cell lineNCI-H4605.0E+4 cells per wellNAMTT assay10 MOI100% cancer cell survival after 48 hoursNoNoNA No responseNAVirus induced apoptosisNANA27080225
OV_4561AdenovirusCD55-TRAILDNAAdenoviridaevirus containing TRAIL geneYesNoNoShanghai cell collectionHuman lung carcinoma cell lineNCI-H4605.0E+4 cells per wellNAMTT assay10 MOI100% cancer cell survival after 48 hoursNoNoNA No responseNAVirus induced apoptosisNANA27080225
OV_4562AdenovirusCD55-TRAIL-IETD-MnSODDNAAdenoviridaeVirus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage siteYesNoNoShanghai cell collectionHuman lung carcinoma cell lineNCI-H4605.0E+4 cells per wellNAMTT assay10 MOI100% cancer cell survival after 48 hoursNoNoNA No responseNAVirus induced apoptosisNANA27080225
OV_4563AdenovirusCD55-TRAIL+ CD55-MnSODDNAAdenoviridaevirus containing TRAIl and MnSOD geneYesNoNoShanghai cell collectionHuman lung carcinoma cell lineNCI-H4605.0E+4 cells per wellNAMTT assay10 MOI100% cancer cell survival after 72 hoursNoNoNA No responseNAVirus induced apoptosisNANA27080225
OV_4564AdenovirusCD55-MnSODDNAAdenoviridaevirus containing MnSOD geneYesNoNoShanghai cell collectionHuman lung carcinoma cell lineNCI-H4605.0E+4 cells per wellNAMTT assay10 MOI100% cancer cell survival after 72 hoursNoNoNA No responseNAVirus induced apoptosisNANA27080225
OV_4565AdenovirusCD55-TRAILDNAAdenoviridaevirus containing TRAIL geneYesNoNoShanghai cell collectionHuman lung carcinoma cell lineNCI-H4605.0E+4 cells per wellNAMTT assay10 MOI100% cancer cell survival after 72 hoursNoNoNA No responseNAVirus induced apoptosisNANA27080225
OV_4566AdenovirusCD55-TRAIL-IETD-MnSODDNAAdenoviridaeVirus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage siteYesNoNoShanghai cell collectionHuman lung carcinoma cell lineNCI-H4605.0E+4 cells per wellNAMTT assay10 MOI100% cancer cell survival after 72 hoursNoNoNA No responseNAVirus induced apoptosisNANA27080225
OV_4567AdenovirusCD55-TRAIL+ CD55-MnSODDNAAdenoviridaevirus containing TRAIl and MnSOD geneYesNoNoShanghai cell collectionHuman lung carcinoma cell lineNCI-H4605.0E+4 cells per wellNAMTT assay10 MOI78% cancer cell survival after 96 hoursNoNoNA No responseNAVirus induced apoptosisNANA27080225
OV_4568AdenovirusCD55-MnSODDNAAdenoviridaevirus containing MnSOD geneYesNoNoShanghai cell collectionHuman lung carcinoma cell lineNCI-H4605.0E+4 cells per wellNAMTT assay10 MOI82% cancer cell survival after 96 hoursNoNoNA No responseNAVirus induced apoptosisNANA27080225
OV_4569AdenovirusCD55-TRAILDNAAdenoviridaevirus containing TRAIL geneYesNoNoShanghai cell collectionHuman lung carcinoma cell lineNCI-H4605.0E+4 cells per wellNAMTT assay10 MOI80% cancer cell survival after 96 hoursNoNoNA No responseNAVirus induced apoptosisNANA27080225
OV_4570AdenovirusCD55-TRAIL-IETD-MnSODDNAAdenoviridaeVirus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage siteYesNoNoShanghai cell collectionHuman lung carcinoma cell lineNCI-H4605.0E+4 cells per wellNAMTT assay10 MOI62% cancer cell survival after 96 hoursNoNoNA No responseNAVirus induced apoptosisNANA27080225
OV_5538Herpes simplex virus1716DNAHerpesviridaeDouble deletion mutant in ICP34.5 geneNoVirus in combination with mitomycin drugNoATCCHuman large cell carcinoma cell line H460H460NANANANANAMouse model xenograft for H460 cell line4.0E+6 pfuNA Reduction in tumor volume to 0.793 +/- 0.047IntravenouslyNANANAUS6428968
OV_5539Herpes simplex virus1716DNAHerpesviridaeDouble deletion mutant in ICP34.5 geneYesNoNoATCCHuman large cell carcinoma cell line H460H460NANANANANAMouse model xenograft for H460 cell line4.0E+6 pfuNA Reduction in tumor volume to 1.127 +/- 0.139IntravenouslyNANANAUS6428968